Source: Annual Congress 2011 - Allergen immunotherapy and anti-immunoglobulin E
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Hoshino (Atami, Japan). Effects of add-on omalizumab therapy on airway wall thickening in severe persistent asthma. Eur Respir J 2011; 38: Suppl. 55, 267

Member's Comments

No comment yet.

Related content which might interest you: Effect of montelukast on excessive airway narrowing in adult asthmatics not on controller therapy Source: Annual Congress 2006 - New developments in the treatment and management of asthma Year: 2006 Effect of add-on montelukast to inhaled corticosteroids on excessive airway narrowing in adult asthmatics Source: Annual Congress 2009 - Aspects of clinical asthma Year: 2009 Immunological effectiveness of atorvastatin in complex therapy of severe persistent bronchial asthma Source: Annual Congress 2009 - Persistent asthma: still an uncontrolled disease requiring new treatments strategies in 2009 Year: 2009 Effects of formoterol-budesonide combination on residual eosinophilic inflammation in distal airway of patients with well-controlled moderate asthma Source: Annual Congress 2011 - Asthma management and response Year: 2011 Influence of combined antiasthmatic basic therapy on hyperinflation in patients with severe bronchial asthma Source: Eur Respir J 2007; 30: Suppl. 51, 553s Year: 2007 Effect of the addition of montelukast on airway inflammation and remodeling in symptomatic asthma Source: International Congress 2017 – Asthma: mechanisms and treatment Year: 2017 Montelukast as add-on therapy may improve some indices of small airways involvement in uncontrolled asthmatics Source: Annual Congress 2011 - Asthma management and response Year: 2011 Effects of regular formoterol treatment on airway hyperresponsiveness in patients with mild to moderate asthma Source: Eur Respir J 2003; 22: Suppl. 45, 285s Year: 2003 The importance of early applying inhaled corticosteroids in patients with mild bronchial asthma Source: Eur Respir J 2002; 20: Suppl. 38, 57s Year: 2002 Immunological effectiveness of N-acetylcystein in complex therapy in severe persistent bronchial asthma patients Source: Annual Congress 2008 - Comorbid cardiovascular condition and therapy of asthma Year: 2008 Heterogeneous response of airway eosinophilia to biologics in severe asthma patients Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies Year: 2021 The oral corticosteroid sparing effect of omalizumab in paediatric patients with severe chronic asthma Source: Annual Congress 2010 - Managing asthma and allergic disease in children Year: 2010 Advances of selenium add-on treatment in severe steroids-dependant bronchial asthma Source: Annual Congress 2010 - Treatment options for asthma Year: 2010 Add-on omalizumab therapy reduces clinically significant and severe asthma exacerbations, and improves FEV1 in patients with severe persistent allergic asthma irrespective of age Source: Eur Respir J 2005; 26: Suppl. 49, 48s Year: 2005 Use of budesonide suspension during the exacerbation of severe steroid-dependent bronchial asthma Source: Eur Respir J 2001; 18: Suppl. 33, 47s Year: 2001 Evaluation of therapeutic response to anti-IL5 treatment in severe eosinophilic asthma patients no responders to omalizumab Source: International Congress 2019 – Treatment of asthma with monoclonal antibodies Year: 2019 Cost-effectiveness of switching from omalizumab to mepolizumab in uncontrolled severe eosinophilic asthma Source: Virtual Congress 2020 – How do different treatment strategies translate into costs Year: 2020 Effects of corticosteroids on airway inflammation in cough variant asthma Source: Annual Congress 2004 - Understanding airway regulation by airway monitoring Year: 2004 Tiotropium add-on therapy reduces seasonal peaks of asthma worsening in adults with symptomatic severe asthma Source: Eur Respir J, 55 (1) 1900964; 10.1183/13993003.00964-2019 Year: 2020 Monitoring of inflammatory changes in patients with bronchial asthma before and after oral corticosteroid treatment Source: Annual Congress 2008 - Novel experimental approaches to understanding asthma and COPD II Year: 2008